Cleared Special

K243609 - EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ) (FDA 510(k) Clearance)

Dec 2024
Decision
26d
Days
Class 2
Risk

K243609 is an FDA 510(k) clearance for the EquivaBone Osteoinductive Bone Graft Substitute (EquivaBone ). This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Etex Corporation (Braintree, US). The FDA issued a Cleared decision on December 18, 2024, 26 days after receiving the submission on November 22, 2024.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K243609 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2024
Decision Date December 18, 2024
Days to Decision 26 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV - Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045